NASDAQ:SGEN
Delisted

Seattle Genetics Stock News

etoro logo Buy SGEN
*Your capital is at risk
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Seagen (NASDAQ: SGEN ) stock is taking off on Monday as investors react to an acquisition deal with Pfizer (NYSE: PFE ). Pfizer is acquiring Seagen for $43 billion in cash.
Pfizer will buy Seagen for roughly $43 billion, and Sanofi will buy Provention for $2.9 billion. SGEN stock and PRVB stock soared.
Pfizer Inc. PFE, -0.18% plans to acquire cancer biotechnology company Seagen Inc. SGEN, -0.59% in a deal with a $43 billion enterprise value, the companies announced Monday morning. Pfizer intends to
As the market indexes fight for support, ANET, WING, BKNG, CDNS, PANW and more land a spot on the IBD Breakout Stocks Index. The post Hot Stocks And Hot Wings Serve Up Spicy Breakouts And Buy Zones ap
Investing in large-cap stocks is considered one of the best ways to invest in the stock market.

These Are the Top 10 Holdings of David Kim

10:55pm, Monday, 06'th Mar 2023
David Kim is the founder and Chief Investment Officer of Ghost Tree Capital. Before founding Ghost Tree Capital in 2013, Kim worked as the portfolio manager at Diamondback Capital (Nov 2006 – Dec 20
The stock market is digesting recent inflation data and earnings reports. Where is the stock market headed next?
The biotech industry has a reputation for being a breeding ground for high-value mergers and acquisitions, which does not come as a surprise given the aggressive push by leading biotech companies to c
Yahoo Finance Live's Brad Smith discusses Monday's trending tickers, including Fisker, Zillow, Seagen, and Union Pacific.
These Durable Goods figures are preliminary, and subject to future revisions.
Biopharma giant Pfizer is eyeing an acquisition of Seagen, the Seattle area's biggest biotech company, according to a report in the Wall Street Journal Monday.
Yahoo Finance Live's Brad Smith summarizes three key topics in markets to pay attention to on Monday morning.
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss reports that Pfizer is in talks to acquire biotech firm Seagen in a $30 billion deal.
Seagen Inc (NASDAQ: SGEN) opened more than 10% up this morning on reports that Pfizer Inc (NYSE: PFE) is interested in buying the cancer therapies company.
Pfizer is in early talks to acquire cancer specialist Seagen, according to a report that sent SGEN stock flying on Monday. The post 'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A Takeov
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE